Corrigendum: Characterization of inflammation and fibrosis in Crohn's disease lesions by magnetic resonance imaging.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Potential Role of Epithelial Endoplasmic Reticulum Stress and Anterior Gradient Protein 2 Homologue in Crohn's Disease Fibrosis.Journal of Crohn's & colitis · 2021
   Article
2. Medical Therapies for Stricturing Crohn's Disease: Efficacy and Cross-Sectional Imaging Predictors of Therapeutic Failure.Digestive diseases and sciences · 2017
   Article
3. Imaging of intestinal fibrosis: current challenges and future methods.United European gastroenterology journal · 2016
   Review
4. Characterization of inflammation and fibrosis in Crohn's disease lesions by magnetic resonance imaging.The American journal of gastroenterology · 2015
   Article

Corrections and comments

• Erratum for
  Characterization of inflammation and fibrosis in Crohn's disease lesions by magnetic resonance imaging.2015

Authors and funding

12 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.